Sign Up
OverviewAPI
Kamada secures FDA approval to produce Cytogam in Israel after successful technology transfer from CSL Behring, aimed at prophylaxis of cytomegalovirus disease in organ transplant patients. The biopharmaceutical company plans to launch commercial manufacturing soon, expecting revenue growth from its FDA-approved IgG portfolio.

Ask a question